These studies convincingly demonstrate a key role for mir181ab1 in regulating the pro-oncogenic transcriptional output of oncogenic KRAS, a finding with potentially profound implications for the search for novel approaches to target KRAS-mutant cancers. Here, KRAS is linked to cancer.